Brand developed in response to priorities and
requests for quality value products from retail partners across the
country
MONCTON, NB, Sept. 26, 2018 /CNW/ - Organigram Holdings Inc.
(TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram
Inc. (the "Company" or "Organigram"), a leading
licensed producer of medical marijuana, today unveiled Trailblazer,
the newest addition to their portfolio of products ready for the
launch of the adult use recreational cannabis market in
Canada.
Trailblazer was developed in rapid response to ongoing
discussions with Organigram's jurisdictional and retail partners
across Canada and their focus on
offering high value offerings. "Our brand strategy is creative and
thoughtful, based on a concerted effort to wholly understand our
current and future customers," explains Ray
Gracewood, Chief Commercial Officer, Organigram.
"We always want to be nimble enough to respond to what our
partners need. Across the country, the message has been clear that
a high value, quality product is an important consideration for
customers and an effective tool to help combat the black market for
cannabis. Trailblazer delivers on both those fronts."
The brand concept behind Trailblazer is a celebration of the end
of prohibition, Gracewood says.
"Forging the path to legalization has taken many years of hard
work by citizens, industry and government, but here we are on the
verge of a legal, adult recreational market in Canada in 2018," Gracewood says. "The brand is
a celebration of that effort and a reminder to always blaze your
own trail."
Trailblazer complements Organigram's premium and organic product
offerings. The new product, currently planned to be sold at a
slight discount to mainstream priced products across Canada, will be available in milled and
pre-rolled varieties and will provide a breadth of low, mid and
higher THC products. The brand's signature Prohibition Blend
is a hybrid offering developed using an optimal blend of Acadia,
one of the Company's best-selling sativa strains, and Critical
Kush, one of the longest-standing indica strains in the Company's
robust genetic library.
"We're very proud to introduce Trailblazer to the nation. It's a
line of products we feel complements and showcases the strength of
our cultivation capabilities and will help set a standard for
exceptional value in this new regulated adult recreational market,"
Gracewood says.
Adult recreational use of cannabis in Canada is expected to be legalized as of
October 17, 2018.
"Our recreational brand strategy incorporates the best of what
we know about our current and potential customers, the industry and
opportunities for growth, and the production of our premium
products," says Greg Engel, CEO,
Organigram. "We are proud to offer Canadians a full portfolio of
product options. Each has been developed with them, and an
exceptional customer experience, in mind."
Adult Recreational Preparedness Update
The Company is pleased to announce that it has shipped its first
order of adult recreational use cannabis to Alberta as of Tuesday,
September 25th, 2018. Currently, Organigram
has supply agreements or memorandums of understanding with seven
provinces including Newfoundland
and Labrador, Prince Edward Island, Nova Scotia, New
Brunswick, Ontario,
Alberta, and
Manitoba.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a TSX Venture Exchange listed
company whose wholly owned subsidiary, Organigram Inc., is a
licensed producer of cannabis and cannabis-derived products in
Canada.
Organigram is focused on producing the highest-quality,
indoor-grown cannabis for patients and adult recreational consumers
in Canada, as well as developing
international business partnerships to extend the Company's global
footprint. In anticipation of the legal adult use recreational
cannabis market in Canada,
Organigram has developed a portfolio of brands including The Edison
Cannabis Company, Ankr Organics, Trailblazer and Trailer Park Buds.
Organigram's primary facility is located in Moncton, New Brunswick and the Company is
regulated by the Access to Cannabis for Medical Purposes
Regulations ("ACMPR").
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
This news release contains forward-looking information which
involves known and unknown risks, uncertainties and other factors
that may cause actual events to differ materially from current
expectations. Important factors - including the interpretation of
the Cannabis Act and promotional activities, the availability of
funds, the results of financing efforts, crop yields - that could
cause actual results to differ materially from the Company's
expectations are disclosed in the Company's documents filed from
time to time on SEDAR (see www.sedar.com). Readers are cautioned
not to place undue reliance on these forward-looking statements,
which speak only as of the date of this press release. The Company
disclaims any intention or obligation, except to the extent
required by law, to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise.
SOURCE OrganiGram